“What are the challenges faced by clinicians when treating people with epilepsy?”
Clinicians aim for seizure freedom in their patients, but what happens when a patient doesn’t respond to treatment?
“Can you tell us about striking the balance between seizure freedom and quality of life when it comes to treating certain patients?”
The challenge for clinicians is finding a treatment that works, yet does not burden the patient with intolerable side effects. What can the clinician do to improve the patient’s quality of life?
“Can you tell us about the risks associated with having epilepsy and the challenges in achieving seizure freedom?”
Tackling the difficult topic of the worst possible outcome: sudden unexpected death in epilepsy.
“What are the challenges presented when treating those with co-morbidities?”
Advice on how to approach the treatment of patients with multiple needs.
“What additional interventions can clinicians put in place to improve patient outcomes?”
Making use of the available resources to support patients, and the hugely beneficial impact of epilepsy nurse specialists.
SUDEP = sudden unexpected death in epilepsy.
P-UK-CE-2100047 December 2021
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should be reported to Arvelle Therapeutics UK on 02034889643 or at UKIReporting@angelinipharma.com.
This site is published and funded by Arvelle Therapeutics UK which is solely responsible for its content. This site is intended exclusively for UK healthcare professionals.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should be reported to Arvelle Therapeutics UK on 02034889643 or at UKIReporting@angelinipharma.com.
This site is published and funded by Arvelle Therapeutics UK which is solely responsible for its content. This site is intended exclusively for UK healthcare professionals.
Listen to leading experts discuss key evolving topics in the field of epilepsy through a focused webinar series, podcasts and more.
UK Website
Prescribing Information and Adverse Event Reporting
